Loading organizations...
Key people at Biosciences Research & Commercialization Center.
The Biosciences Research and Commercialization Center (BRCC) provides startup and gap funding to promising Michigan-based life sciences and medical device ventures. It supports companies entering the commercialization phase, aiding innovations across pharmaceuticals, diagnostics, and medical technologies. The center strategically invests to bridge the gap between scientific discoveries and market applications, leveraging regional expertise.
Established in 2003 by the Michigan Legislature, the BRCC operates in affiliation with Western Michigan University, within Kalamazoo’s biopharmaceutical and medical technology ecosystem. This institutional creation recognized the region's historical ties to life sciences and its capacity to foster innovation. The center’s strategic placement grants access to significant scientific talent and commercialization experience locally.
The BRCC serves entrepreneurs, academic scientists, university technology transfer offices, and corporations developing new products. Its long-term vision focuses on cultivating a robust life sciences industry in Michigan, facilitating the transition of groundbreaking research into commercial entities. The organization aims to foster economic growth by supporting innovation and new enterprise creation.
Key people at Biosciences Research & Commercialization Center.
Biosciences Research & Commercialization Center has 5 tracked investments across 3 companies. The latest tracked deal is $2.0M Seed in Asalyxa Bio in February 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2021 | Asalyxa Bio | $2.0M Seed | ID Ventures, JIM Graham | ANN Arbor SPARK, Michigan Rise, Woodward Angels |
| Sep 3, 2015 | Tetra Discovery | $1.0M Other Equity | Grand Angels | Invest Michigan, J & J Investments, Muskegon Angels |
| Sep 30, 2013 | Tetra Discovery | $1.0M Seed | Grand Angels | Michigan |
| Apr 11, 2012 | Sierra Oncology | $1.0M Other Equity | — | 21st Century Jobs Fund, Amherst Fund, Apjohn Ventures, Grand Angels, Michigan Technology TRI Corridor, Sigvion Capital |
| Aug 28, 2007 | Sierra Oncology | $12.0M Debt / Other Equity | Comerica Bank, Oxford Finance | Amherst Fund, Apjohn Ventures, Grand Angels, Michigan Economic Development Corporation, Michigan Technology TRI Corridor, Sigvion Capital |